Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-β1 in human breast cancer cells
- 6 December 2001
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 20 (56), 8066-8074
- https://doi.org/10.1038/sj.onc.1204944
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.This publication has 29 references indexed in Scilit:
- Survey of life-cycle measures and metrics for concurrent product and process designArtificial Intelligence for Engineering Design, Analysis and Manufacturing, 2000
- Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cellsOncogene, 1999
- Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascadesOncogene, 1997
- Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymesFEBS Letters, 1996
- Modulation of Mr 72,000 and Mr 92,000 type-IV collagenase (gelatinase A and B) gene expression by interferons alpha and gamma in human melanomaInternational Journal of Cancer, 1994
- Identification of Heregulin, a Specific Activator of p185 erbB2Science, 1992
- Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unitCell, 1992
- Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cellsCell, 1992
- Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185
erb
B2
Science, 1990
- Ras oncogene mediated induction of a 92kDa metalloproteinase; strong correlation with the malignant phenotypeBiochemical and Biophysical Research Communications, 1988